Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Item
http://www.wikidata.org/entity/Q36033853
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialAdvances and Challenges of Liposome Assisted Drug DeliveryDevelopment of nanoscale approaches for ovarian cancer therapeutics and diagnosticsThe Globalization of Cooperative Groups.Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.Cancer therapies utilizing the camptothecins: a review of the in vivo literatureBest practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.A Bayesian pick-the-winner design in a randomized phase II clinical trial.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Item
http://www.wikidata.org/entity/Q36033853
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Randomized trial of two intrav ...... Canada clinical trials group.
@ast
Randomized trial of two intrav ...... Canada clinical trials group.
@en
type
label
Randomized trial of two intrav ...... Canada clinical trials group.
@ast
Randomized trial of two intrav ...... Canada clinical trials group.
@en
prefLabel
Randomized trial of two intrav ...... Canada clinical trials group.
@ast
Randomized trial of two intrav ...... Canada clinical trials group.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Randomized trial of two intrav ...... f Canada clinical trials group
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921